ISMP Medication Safety Alert!®

Community/Ambulatory

A valuable resource to reduce medication error risk in outpatient settings

The ISMP Medication Safety Alert!®Community/Ambulatory Care is a digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, specialty pharmacies, outpatient clinics, physician offices, and state institutions.

Who reads this newsletter?

  • Community/ambulatory/specialty care pharmacists
  • Pharmacy managers and executives
  • Pharmacy technicians and other pharmacy staff
  • Physicians and nurses in ambulatory practice
  • Anyone concerned with medication safety

Subscription Options

Online access to twelve (12) issues per year. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Single issues are available for purchase. 

Academic-based subscription: contact ISMP for pricing

Pharmaceutical Industry (and other healthcare related companies): contact ISMP for pricing

Chain Pharmacies & Multi Site organizations: contact ISMP for pricing


 

Personal Subscription

Subscription Information

  • $75.00 per year
  • Online access for one (1) user (personal usage only)
  • No redistribution is permitted
Single Site Subscription

Subscription Information for healthcare organizations (e.g. hospitals, clinics, pharmacies)

  • $110.00 per year
  • Online access for users within a single site organization
  • Permission to redistribute within single-site location 
  • Instructions to add users to a subscription will be emailed to the user purchasing the subscription
  • Please use your organization email address when subscribing
  • Chain pharmacies/Multi-site organizations: Contact ISMP for pricing

Browse Issues

This month's main topic: Leadership Support is Vital: If We Fail to Support Caregivers, There Will Be Few Left to Support Care
This month's main topic: Patient Taking Hydroxychloroquine Right After Discontinuing Azithromycin Develops QTc Prolongation and Cardiac Arrest
This month's main topic: QuarterWatchTM (includes new data from Quarter 2, 2019): Preventable Methotrexate Errors and Trends Among Addictive Drugs